Duquesne Family Office’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-994,289
Closed -$2.45M 67
2022
Q4
$2.45M Hold
994,289
0.12% 49
2022
Q3
$4.96M Hold
994,289
0.28% 48
2022
Q2
$4.23M Hold
994,289
0.31% 30
2022
Q1
$9.91M Hold
994,289
0.43% 28
2021
Q4
$7.8M Hold
994,289
0.28% 35
2021
Q3
$17.3M Hold
994,289
0.56% 32
2021
Q2
$21.4M Hold
994,289
0.53% 37
2021
Q1
$26.7M Buy
+994,289
New +$31.1M 0.59% 42

Other funds holding OSCR

Duquesne Family Office's OSCR Position: Q1 2023 in Review

Duquesne Family Office sold out of Oscar Health (OSCR) in Q1 2023, closing a stake of 994,289 shares — an estimated $2.45M sold.

Duquesne Family Office first reported a position in OSCR in Q1 2021 and held it in 8 quarters. The position peaked at $26.7M in Q1 2021. 134 funds tracked by Wall St. Rank hold OSCR as of Q1 2023.

  • Duquesne Family Office reported no remaining Oscar Health position as of Q1 2023 after selling out during the quarter.
  • Duquesne Family Office sold 994,289 Oscar Health shares in Q1 2023, an estimated $2.45M.
  • Duquesne Family Office first reported a position in Oscar Health in Q1 2021 and held it in 8 quarters.
  • Duquesne Family Office's Oscar Health position peaked at $26.7M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held Oscar Health as of Q1 2023.

Based on Duquesne Family Office's 13F filing for Q1 2023, filed 15 May 2023.